Advertisement

Springer Nature is making SARS-CoV-2 and COVID-19 research free. View research | View latest news | Sign up for updates

Formulation of Liposome for topical delivery of arbutin

Abstract

The aims of this study were to encapsulate arbutin (AR) in liposome to enhance the skin-whitening activity, and to investigate the effect of liposome formulation on the entrapment efficiency (EE%), skin permeation rate and skin deposition. The liposomes were prepared by a film dispersion method with several different formulations and were separated from the solution by using the gel-filtration method. The physical (size distribution, morphology) and chemical (drug entrapment efficiency, hairless mouse skin permeation and deposition) properties of liposomes were characterized. The entrapment efficiency in all liposome formulations varied between 4.35% and 17.63%, and was dependent on the lipid content. The particle sizes of liposomes were in the range of 179.9–212.8 nm in all liposome formulations. Although the permeation rate of AR in the liposome formulations decreased compared with AR solution, the deposition amount of AR in the epidermis/dermis layers increased in AR liposomal formulation. These results suggest that liposomal formulation could enhance the skin deposition of hydrophilic skin-whitening agents, thereby enhancing their activities.

This is a preview of subscription content, log in to check access.

We’re sorry, something doesn't seem to be working properly.

Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.

References

  1. Abraham, W. and Downing, D. T., Interaction between corneocytes and stratum corneum lipid liposomes in vitro.Biochim. Biophys. Acta-Biomembranes., 1021, 119–125 (1990).

  2. Bian, S. J., Doh, H. J., Zheng, J. M., Kim, J. S., Lee, C. H., and Kim, D. D., In vitro evaluation of patch formulations for topical delivery of gentisic acid in rats.Eur. J. Pharm. Sci., 18, 141–147 (2003).

  3. Bonina, F. P., Montengro, L., Scrofani, N., Esposito, E., Cortesi, R., Menegatti, E., and Nastruzzi, C., Effects of phospholipid based formulations on in vitro and in vivo percutaneous absorption of methyl nicotinate.J. Controlled Rel., 34, 53–63 (1995).

  4. Egabaria, K. and Weiner, N., Liposomes as a topical drug delivery system.Adv. Drug. Deliv. Rev., 5, 287–300 (1984).

  5. Ganesan, M. G., Weiner, N. D., Flynn, L., and Ho, N. F. H., Influence of liposomal drug entrapment on percutaneous absorption.Int. J. Pharm., 20, 139–154 (1984).

  6. Gesztes, A. and Mezei, M., Topical anethesics of the skin by liposome encapsulated teracine.Anaesth Analg., 67, 1079–1081 (1988).

  7. Hincha, D. K., Oliver, A. E., and Crowe, J. H., Lipid Composition Determines the Effects of Arbutin on the Stability of Membranes.Biophysical J., 77, 2024–2034 (1999).

  8. Ho, N. F. H., Ganesan, M., Weiner, N. D., and Flynn, L., Mechanism of topical delivery of liposomally entrapped drug.J. Control. Rel., 2, 61–65 (1985).

  9. Imura, T., Sakai, H., Yamauchi, H., Kaise, C., Kozawa, K., Yokoyama, S., and Abe, M., Preparation of liposomes containing Ceramide 3 and their membrane characteristics: Colloids and Surfaces B.Biointerfaces., 20, 1–8 (2001).

  10. Manosroi, A., Kogkaneamit, L., and Manosroi, J., Stability and transdermal absorption of topical amphotericin B liposome formulations.Int. J. Pharm., 235, 61–70 (2004).

  11. Manosroi, A., Podjanasoonthon, K., and Manosroi, J., Development of novel topical tranexamic acid liposome formulations.Int. J. Pharm., 270, 279–286 (2002).

  12. Mezei, M. and Gulasekharam, V., Liposomes a selective drug delivery system for the topical route of administration. Lotion Dosage forms.Life Sci., 26, 1473–1477 (1980).

  13. Mezei, M. and Gulasekharam, V., Liposomes a selective drug delivery system for the topical route of administration. gel dosage.J. Pharm. Pharmacol., 34, 473–474 (1982).

  14. Nastruzzi, C., Walde, P., Menegatti, E., and gambari, R., Liposome-associated retinoic acid Increasedin vitro antiproliferative effects on neoplastic cells.FEBS letters., 259, 293–296 (1990).

  15. Planas, M. E., Gonzalez, P., Rodriguez, L., Sanchez, S., and Cevc, G., Noninvasive percutaneous induction of topical analgesia by a new type of drug carrier and prolongation of local pain insensitivity by anesthetic liposomes.Anesth. Analg., 75, 615–621 (1992).

  16. Rowe, T. C., Mezei, M., and Hilchie, J., Treatment of hirsutism with liposomal Progesterone.Prostate, 5, 346–347 (1984).

  17. Wester, R. C., Szoka, F. C., Bucks, D. A. W., and Maibach, H. I.,Abstracts Am. Pharm. Assoc. Acad. Pharm. Sci, 37 th National Meeting, 14, 229–229. 1984.

  18. Vermorken, A. H., Hukkelhoven, M. W., Vermeesch A. M., Goos, L. M., and Wirtz, P., The use of liposomes in the topical application of steroids.J. Pharm. Pharmacol., 36, 334–336 (1983).

Download references

Author information

Correspondence to Dae-Duk Kim.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Wen, A., Choi, M. & Kim, D. Formulation of Liposome for topical delivery of arbutin. Arch Pharm Res 29, 1187 (2006). https://doi.org/10.1007/BF02969312

Download citation

Key words

  • Arbutin
  • Liposome
  • Entrapment efficiency
  • Skin permeation
  • Skin deposition